Skip to main content

Octavian Therapeutics

  • | Biotech or pharma, therapeutic R&D

Octavian is at the frontier of precision pain management, developing innovative, non-addictive, small-molecule medicines that target the endocannabinoid system (ECS) to address the global challenge of chronic pain, which affects over 1.5 billion 1 people and drives dangerous dependence on opioids

Address

United States

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors